The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Over the past six months, Altasciences has completed nonclinical work for MET-233i, an ultra-long-acting injectable amylin ...

Overview: Gan & Lee Pharmaceuticals is a biopharmaceutical company focused on the research, development, production, and sale of insulin analog APIs and injections ... Recent positive clinical trial ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were mostly higher early Tuesday after the Biden administration proposed a rule that would allow Medicare ...

“Especially in the ones for the GLP (Glucagon-like Peptide) analogue space, that’s one of the complex generics that Orbicular ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

Despite disappointing results in the genetic neurodegenerative disorder, the drug shows potential for treating obesity.

Nature and The Economist reported on the research.

In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

Similarly, zinc may contribute to GI issues like diarrhea or cramping. Many immune-supporting supplements combine vitamin C ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...